PEOPLE - ev3 makes appointments:
This article was originally published in Clinica
Endovascular device maker, ev3 (Plymouth, Minnesota) has appointed Robert Palmisano as president, CEO and director; director Dan Levangie is named as chairman of the board. Together they replace James Corbett, who has resigned as president, CEO and chairman. Mr Palmisano joins from IntraLase (ophthalmic laser tech - acquired by Advanced Medical Optics in 2007), where he was president and CEO. Mr Levangie is on the board of Hologic (medical imaging), following its acquisition of Cytyc (2007) of which he was executive vice president, a member of the board and president of the surgical products division.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.